CARM logo

Carisma Therapeutics, Inc. (CARM)

Profile

Full Name

Carisma Therapeutics, Inc.

Ticker

NASDAQ: CARM

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 6, 2014

Indexes

Not included

Website

https://www.carismatx.com

Employees

46

Key Details

Price

$0.23(-4.02%)

Market cap

Last Dividend

$0.36

TTM Dividend yield

-

Annual revenue

$19.63M(+31.59% YoY)

Annual EPS

-$1.46(+43.63% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.23
    CARM price is $0.23

    30-Day Relative Volume

    1.44
    CARM 30-day relative volume is 1.44

    Price Performance

    Price Today change

    -4.02%
    CARM price is down -4.02% today

    Price YTD change

    -45.25%
    CARM price is down -45.25% since January 1st

    Price 1-year change

    -81.65%
    CARM price is down -81.65% year-on-year

    Price 3-year change

    -98.34%
    CARM price is down -98.34% over the past 3 years

    Price Range

    Price All-time high

    $386.66
    CARM price is currently -99.94% below its historical high of $386.66

    Price 3-year low

    $0.14
    CARM price is currently +61.55% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $9.59M
    CARM market capitalization is $9.59 million

    Market cap 3-year change

    -93.03%
    CARM market capitalization is down -93.03% over the past 3 years

    Market cap All-time high

    $962.37M
    CARM market capitalization is currently -99.00% below its historical high of $962.37 million

    Market cap sector rank

    16.17%
    CARM market capitalization is higher than 16.17% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.59%
    CARM shares outstanding is up +0.59% year-on-year

    Shares Outstanding 3-Year Change

    +319%
    CARM shares outstanding is up +319% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.72
    CARM beta is 1.72

    200-day SMA

    $0.44
    CARM price is currently -47.41% below its 200-day simple moving average

    50-day SMA

    $0.39
    CARM price is currently -41.40% below its 50-day simple moving average

    RSI

    30.26
    CARM 14-day relative strength index is 30.26

    Volume

    1.44
    CARM 30-day relative volume is 1.44

    ATR

    $0.03
    CARM average true range is $0.03

    10-day Historical Volatility

    96.33%
    CARM 10-day historical volatility is 96.33%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.36
    CARM last dividend was $0.36 per share, with an ex-dividend date of March 8, 2023

    Next Dividend

    -
    CARM next dividend has not yet been announced

    Dividend per share

    Dividend per share

    -
    CARM annual dividend per share value is unknown

    Dividend per share Sector Rank

    -
    CARM annual dividend per share is unknown

    Dividend per share 1-Year Change

    -
    CARM annual dividend per share 1-year change is unknown

    Dividend per share 3-Year Change

    -
    CARM annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    -
    CARM annual dividend yield value is unknown

    Dividend yield Sector Rank

    -
    CARM annual dividend yield is unknown

    Other

    Payout ratio

    0.00%
    CARM annual payout ratio is 0.00%

    Dividends paid

    $0.00
    CARM annual dividends paid is $0.00

    Free cash flow

    -$60.04M
    CARM annual free cash flow is -$60.04 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $19.63M
    CARM annual revenue is $19.63 million

    Revenue Analysts estimate

    -
    CARM annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    +31.59%
    CARM annual revenue is up +31.59% year-on-year

    Revenue Sector rank

    52.51%
    CARM annual revenue is higher than 52.51% of companies in Healthcare sector

    EPS

    EPS

    -$1.46
    CARM annual earnings per share is -$1.46

    EPS Analysts estimate

    -$0.69
    CARM annual earnings per share is currently +111.59% higher than the consensus analysts' forecast

    EPS 1-year change

    +43.63%
    CARM annual earnings per share is up +43.63% year-on-year

    EPS Sector rank

    43.49%
    CARM annual earnings per share is higher than 43.49% of companies in Healthcare sector

    Profit

    Gross profit

    $16.28M
    CARM annual gross profit is $16.28 million

    Gross margin

    82.92%
    CARM annual gross profit margin is 82.92%

    Operating profit

    -$62.18M
    CARM annual operating income is -$62.18 million

    Operating margin

    -316.72%
    CARM annual operating profit margin is -316.72%

    Net income

    -$60.48M
    CARM annual net profit is -$60.48 million

    Net margin

    -308.05%
    CARM annual net profit margin is -308.05%

    Expenses

    Total expenses

    $80.11M
    CARM annual total expenses is $80.11 million

    Operating expenses

    $78.46M
    CARM annual total operating expenses is $78.46 million

    Cost of goods sold

    $3.35M
    CARM annual cost of goods sold is $3.35 million

    Selling, general & administrative expenses

    $0.00
    CARM annual SGA is $0.00

    Depreciation and amortization

    $3.35M
    CARM annual depreciation & amortization is $3.35 million

    Interest expense

    $0.00
    CARM annual interest expense is $0.00

    Income tax

    $0.00
    CARM annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$62.18M
    CARM annual earnings before interest & taxes is -$62.18 million

    EBITDA

    -$58.83M
    CARM annual EBITDA is -$58.83 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $30.46M
    CARM annual total assets is $30.46 million

    Non current assets

    $6.63M
    CARM annual long term assets is $6.63 million

    Current assets

    $23.82M
    CARM annual total current assets is $23.82 million

    Cash and cash equivalents

    $17.91M
    CARM annual cash & cash equivalents is $17.91 million

    Accounts receivable

    -
    CARM annual accounts receivable value is unknown

    Inventory

    $0.00
    CARM annual inventory is $0.00

    Liabilities

    Total liabilities

    $58.37M
    CARM annual total liabilities is $58.37 million

    Long term liabilities

    $42.31M
    CARM annual total long term liabilities is $42.31 million

    Current liabilities

    $16.05M
    CARM annual total current liabilities is $16.05 million

    Accounts payable

    $2.08M
    CARM annual accounts payable is $2.08 million

    Debt

    Total debt

    $2.48M
    CARM annual total debt is $2.48 million

    Total debt 1-year change

    -20.56%
    CARM annual total debt is down -20.56% year-on-year

    Long term debt

    $744.00K
    CARM annual long term debt is $744.00 thousand

    Short term debt

    $1.74M
    CARM annual short term debt is $1.74 million

    Equity & Capital

    Shareholders equity

    -$27.91M
    CARM annual stockholders equity is -$27.91 million

    Book value

    -$27.91M
    CARM annual book value is -$27.91 million

    Retained earnings

    -$305.58M
    CARM annual retained earnings is -$305.58 million

    Working capital

    $7.77M
    CARM annual working capital is $7.77 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$59.92M
    CARM annual cash flow from operations is -$59.92 million

    Cash from operations 1-year change

    +26.32%
    CARM annual cash flow from operations is up +26.32% year-on-year

    Cash from investing

    -$123.00K
    CARM annual cash flow from investing activities is -$123.00 thousand

    Cash from investing 1-year change

    -100.17%
    CARM annual cash flow from investing activities is down -100.17% year-on-year

    Cash from financing

    $344.00K
    CARM annual cash flow from financing activities is $344.00 thousand

    Cash from financing 1-year change

    -99.45%
    CARM annual cash flow from financing activities is down -99.45% year-on-year

    CAPEX

    CAPEX

    $123.00K
    CARM annual capital expenditures is $123.00 thousand

    CAPEX 1-year change

    -89.13%
    CARM annual capital expenditures is down -89.13% year-on-year

    Free Cash Flow

    Free cash flow

    -$60.04M
    CARM annual free cash flow is -$60.04 million

    Free cash flow 1-year change

    +27.18%
    CARM annual free cash flow is up +27.18% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    82.92%
    CARM annual gross profit margin is 82.92%

    Operating margin

    -316.72%
    CARM annual operating profit margin is -316.72%

    Net margin

    -308.05%
    CARM annual net profit margin is -308.05%

    ROA & ROE

    ROA

    -100.78%
    CARM annual return on assets is -100.78%

    ROE

    216.69%
    CARM annual return on equity is 216.69%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CARM price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CARM price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -0.21
    CARM price to book ratio is -0.21

    PB ratio Sector rank

    13.32%
    CARM price to book ratio is higher than 13.32% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.89
    CARM price to sales ratio is 0.89

    PS ratio Sector rank

    20.98%
    CARM price to sales ratio is higher than 20.98% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $9.29M
    CARM enterprise value is $9.29 million

    Enterprise value Sector rank

    22.93%
    CARM enterprise value is higher than 22.93% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.22
    CARM EV/EBITDA is -0.22

    EV/EBITDA Sector rank

    58.61%
    CARM EV/EBITDA is higher than 58.61% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.48
    CARM annual current ratio is 1.48

    Quick ratio

    1.48
    CARM annual quick ratio is 1.48

    Leverage

    Debt to equity

    -0.09
    CARM annual debt to equity ratio is -0.09

    Interest coverage ratio

    -
    CARM annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    CARM piotroski f-score value is unknown

    Altman Z-Score

    -19.73
    CARM altman z-score is -19.73

    Analyst ratings

    Recent major analysts updates

    Aug 8, 25 D. Boral Capital
    Buy
    Apr 1, 25 D. Boral Capital
    Buy
    Jan 17, 25 D. Boral Capital
    Buy
    Jan 13, 25 D. Boral Capital
    Buy
    Dec 16, 24 HC Wainwright & Co.
    Neutral
    Dec 12, 24 D. Boral Capital
    Buy
    Dec 12, 24 Baird
    Neutral
    Dec 11, 24 Evercore ISI Group
    In-Line
    Dec 10, 24 BTIG
    Neutral
    Dec 9, 24 D. Boral Capital
    Buy

    Institutional Ownership

    Screeners with CARM included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for Carisma Therapeutics, Inc.?
    • Does Carisma Therapeutics, Inc. pay dividends?
    • What sector is Carisma Therapeutics, Inc. in?
    • What industry is Carisma Therapeutics, Inc. in?
    • What country is Carisma Therapeutics, Inc. based in?
    • When did Carisma Therapeutics, Inc. go public?
    • Is Carisma Therapeutics, Inc. in the S&P 500?
    • Is Carisma Therapeutics, Inc. in the NASDAQ 100?
    • Is Carisma Therapeutics, Inc. in the Dow Jones?
    • When was Carisma Therapeutics, Inc.'s last earnings report?
    • When does Carisma Therapeutics, Inc. report earnings?

    What is the ticker symbol for Carisma Therapeutics, Inc.?

    The ticker symbol for Carisma Therapeutics, Inc. is NASDAQ:CARM

    Does Carisma Therapeutics, Inc. pay dividends?

    No, Carisma Therapeutics, Inc. does not pay dividends

    What sector is Carisma Therapeutics, Inc. in?

    Carisma Therapeutics, Inc. is in the Healthcare sector

    What industry is Carisma Therapeutics, Inc. in?

    Carisma Therapeutics, Inc. is in the Biotechnology industry

    What country is Carisma Therapeutics, Inc. based in?

    Carisma Therapeutics, Inc. is headquartered in United States

    When did Carisma Therapeutics, Inc. go public?

    Carisma Therapeutics, Inc.'s initial public offering (IPO) was on February 6, 2014

    Is Carisma Therapeutics, Inc. in the S&P 500?

    No, Carisma Therapeutics, Inc. is not included in the S&P 500 index

    Is Carisma Therapeutics, Inc. in the NASDAQ 100?

    No, Carisma Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Carisma Therapeutics, Inc. in the Dow Jones?

    No, Carisma Therapeutics, Inc. is not included in the Dow Jones index

    When was Carisma Therapeutics, Inc.'s last earnings report?

    Carisma Therapeutics, Inc.'s most recent earnings report was on August 7, 2025

    When does Carisma Therapeutics, Inc. report earnings?

    The date for Carisma Therapeutics, Inc.'s next earnings report has not been announced yet
    On this page